| Systematic (IUPAC) name | |
|---|---|
| Trisodium {(2-(R)-[(4,4-diphenylcyclohexyl) phosphonooxymethyl]-diethylenetriaminepentaacetato)(aquo) gadolinium(III) | |
| Clinical data | |
| Trade names | Vasovist, Ablavar |
| Pregnancy cat. | C(US) |
| Legal status | ℞-only (US) |
| Routes | Intravenous |
| Identifiers | |
| CAS number | 193901-90-5 |
| ATC code | V08CA11 |
| PubChem | CID 158440 |
| DrugBank | DB06705 |
| ChemSpider | 139381 |
| Chemical data | |
| Formula | C33H40GdN3Na3O15P |
| Mol. mass | 975.88 g/mol |
| SMILES | eMolecules & PubChem |
|
|
Gadofosveset (trade names Vasovist, Ablavar) is a gadolinium-based MRI contrast agent. It is used in form of the trisodium salt.[1][2]